Credit Suisse’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-159,157
| Closed | -$213K | – | 3106 |
|
|
2023
Q3 | $213K | Sell |
159,157
-5,740
| -3% | -$7.69K | ﹤0.01% | 3009 |
|
|
2023
Q2 | $297K | Buy |
164,897
+43,408
| +36% | +$78.1K | ﹤0.01% | 2992 |
|
|
2023
Q1 | $202K | Buy |
121,489
+5,294
| +5% | +$8.79K | ﹤0.01% | 3096 |
|
|
2022
Q4 | $223K | Buy |
116,195
+31,663
| +37% | +$60.8K | ﹤0.01% | 3134 |
|
|
2022
Q3 | $189K | Buy |
84,532
+648
| +0.8% | +$1.45K | ﹤0.01% | 3253 |
|
|
2022
Q2 | $271K | Buy |
83,884
+7,115
| +9% | +$23K | ﹤0.01% | 3192 |
|
|
2022
Q1 | $403K | Buy |
76,769
+3,579
| +5% | +$18.8K | ﹤0.01% | 3075 |
|
|
2021
Q4 | $621K | Sell |
73,190
-13,183
| -15% | -$112K | ﹤0.01% | 2884 |
|
|
2021
Q3 | $858K | Buy |
86,373
+200
| +0.2% | +$1.99K | ﹤0.01% | 2681 |
|
|
2021
Q2 | $795K | Buy |
+86,173
| New | +$795K | ﹤0.01% | 2774 |
|